Sculptra® is approved by the FDA for restoration and/or correction of the signs of facial fat loss, or lipoatrophy, in people with human immunodeficiency virus. Sculptra® is a synthetic, biocompatible material that is injected below the surface of the skin in the area of fat loss. It provides a gradual and significant increase in skin thickness, improving the appearance of folds and sunken areas. In a clinical study, the effects lasted for up to 2 years after the first treatment session in most patients. The results from Sculptra® are not immediate; Sculptra® provides a gradual increase in skin thickness. When the method is FDA approved and is being used for the recommended indication, I consider it to be medically necessary.
Engelhard et al. Saftey of Sculptra®: a review of clinical trial data. Journal of Cosmetic and Laser Therapy. 2005; 7: 201-205.
M Lafaurie et al. Treatments of facial Lipoatrophy with Intradermal injections of Polylactic Acid in HIV-infected patients. J Acquir Immune Defic Syndr, 2005; 38:4 393-398.
C.M. Burgess et al. Assessment if the safety and efficacy of poly-L-lactic acid or the treatment of HIV- associated facial lipoatrophy. J AM ACAD DERMATOL. Feb 2005.